InSimili
PrivateLast Round
Grant
Jun 4, 2025
Total Funding Raised
$226,000
Company Overview
InSimili operates in Healthcare & Life Sciences and is based in Bologna. Its latest recorded funding round was a Grant round in June 2025.
InSimili is a biotechnology company that develops and markets oxygen-regulating microplate technology to improve the drug discovery process by mimicking human physiological conditions in vitro.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
InSimili Comparables
Compare InSimili with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Semarion | 79% | |
| SynVivo | 78% | |
| TissUse | 77% |
For institutional investors. Book with your work email.
InSimili Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 4, 2025 | ||||
| Grant | Jan 29, 2025 | ||||
| Seed | Jul 19, 2024 | ||||
| Accelerator | Apr 27, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
InSimili Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 4, 2025
$65K grant received from Tehnopol-EE.
- Jan 29, 2025
$5K grant received from Society for Laboratory Automation and Screening
For institutional investors. Book with your work email.
InSimili Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about InSimili's valuation, stock price, and market status.
Is InSimili a public or private company?
InSimili is a private company.
What is the current stock price of InSimili?
InSimili is a private company, so its shares have no public market price. Caplight tracks InSimili's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is InSimili worth (valuation)?
Valuation information for InSimili is not publicly available.
Can I buy InSimili stock?
InSimili shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was InSimili's last funding round?
InSimili's most recent funding round was Grant on June 4, 2025.
Who are the main investors in InSimili?
Key investors in InSimili include Almacube, G-Factor.
Will InSimili IPO soon?
No public IPO plans have been announced for InSimili.
How can I track InSimili secondary market activity?
Caplight tracks bids, offers, and trades in InSimili's shares on secondary markets.